These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8501150)

  • 41. Serum bone Gla protein as a marker of bone turnover in acromegaly.
    Marazuela M; Astigarraga B; Tabuenca MJ; Estrada J; Marín F; Lucas T
    Calcif Tissue Int; 1993 Jun; 52(6):419-21. PubMed ID: 8369987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly.
    Puder JJ; Nilavar S; Post KD; Freda PU
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1972-8. PubMed ID: 15634715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin-like growth factor-I in men with idiopathic osteoporosis.
    Kurland ES; Rosen CJ; Cosman F; McMahon D; Chan F; Shane E; Lindsay R; Dempster D; Bilezikian JP
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2799-805. PubMed ID: 9284699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-term effects of growth hormone and insulin-like growth factor I on cancellous bone in rhesus macaque monkeys.
    Sass DA; Jerome CP; Bowman AR; Bennett-Cain A; Ginn TA; LeRoith D; Epstein S
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1202-9. PubMed ID: 9100597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urinary growth hormone excretion in acromegaly: diagnostic value in mild disease activity.
    Main KM; Lindholm J; Vandeweghe M; Skakkebaek NE
    Acta Endocrinol (Copenh); 1993 Nov; 129(5):409-13. PubMed ID: 8279221
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effective clinical response to long term octreotide treatment, with reduced serum concentrations of growth hormone, insulin-like growth factor-I, and the amino-terminal propeptide of type III procollagen in acromegaly.
    Salmela PI; Juustila H; Pyhtinen J; Jokinen K; Alavaikko M; Ruokonen A
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1193-201. PubMed ID: 2180976
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome.
    Piovesan A; Terzolo M; Reimondo G; Pia A; Codegone A; Osella G; Boccuzzi A; Paccotti P; Angeli A
    Horm Metab Res; 1994 May; 26(5):234-7. PubMed ID: 8076906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The place of insulin-like growth factor I in the diagnosis of acromegaly].
    Dohán O; Góth M; Szabolcs I; Kovács L; Kovács Z; Szilágyi G
    Orv Hetil; 1993 Oct; 134(42):2301-3. PubMed ID: 8233444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU; Post KD; Powell JS; Wardlaw SL
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study.
    Battista C; Chiodini I; Muscarella S; Guglielmi G; Mascia ML; Carnevale V; Scillitani A
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):378-82. PubMed ID: 18616713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone metabolic disorder in patients with prostate cancer receiving androgen deprivation therapy (ADT): impact of ADT on the growth hormone/insulin-like growth factor-1/parathyroid hormone axis.
    Isahaya E; Hara N; Nishiyama T; Hoshii T; Takizawa I; Takahashi K
    Prostate; 2010 Feb; 70(2):155-61. PubMed ID: 19760629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
    J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine.
    Kayath MJ; Vieira JG
    Osteoporos Int; 1997; 7(3):226-30. PubMed ID: 9205635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly.
    Sucunza N; Barahona MJ; Resmini E; Fernández-Real JM; Ricart W; Farrerons J; Rodríguez Espinosa J; Marin AM; Puig T; Webb SM
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3889-96. PubMed ID: 19723758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Altered biochemical markers of bone turnover in humans during 120 days of bed rest.
    Inoue M; Tanaka H; Moriwake T; Oka M; Sekiguchi C; Seino Y
    Bone; 2000 Mar; 26(3):281-6. PubMed ID: 10710002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid decline in bone turnover markers but not bone mineral density in acromegalic patients after transsphenoidal surgery.
    Tamada D; Kitamura T; Onodera T; Tabuchi Y; Fukuhara A; Oshino S; Saitoh Y; Hamasaki T; Otsuki M; Shimomura I
    Endocr J; 2014; 61(3):231-7. PubMed ID: 24304925
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcium and Bone Turnover Markers in Acromegaly: A Prospective, Controlled Study.
    Constantin T; Tangpricha V; Shah R; Oyesiku NM; Ioachimescu OC; Ritchie J; Ioachimescu AG
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2416-2424. PubMed ID: 28407138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.